Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity

Mădălin Mihai

By Vijay Kumar Malesu Reviewed by Susha Cheriyedath, M.Sc. Nov 26 2024 A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite . Image Credit: Corona Borealis Studio / Shutterstock In a recent study published in The New England Journal of Medicine , researchers in the Netherlands evaluated the

din zilele anterioare